NCT02492412View on ClinicalTrials.gov

Efficacy and Safety of HE10 for Dry Eye Syndrome

PHASE3CompletedINTERVENTIONAL

Enrollment

101

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

July 31, 2014

Study Completion Date

September 30, 2014

Conditions

Dry Eye Syndrome

Interventions

DRUG

HE 10

DRUG

Restasis

All Listed Sponsors

lead

Huons Co., Ltd.

INDUSTRY

NCT02492412 - Efficacy and Safety of HE10 for Dry Eye Syndrome | Biotech Hunter | Biotech Hunter